Glano SRL
The score of Glano shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +203 % Total assets -11 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Glano's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −6,450 € | ||||
| Equity | 40,901 € | ||||
| Cash | 15,136 € | ||||
| EBITDA | 44,307 € | ||||
| Total assets | 290,512 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Sep 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 12 Oct 2023
- Year ended 31 Dec 2021filed on 17 Oct 2022
Glano's financial analysis
- Solvency14.1%sector median: 47.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Glano
Glano's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0814.785.548
- VAT number
- BE0814785548
- Peppol
- Registered · 0208:0814785548 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Jun 2009
- Registered office
- 9090 Merelbeke-Melle
- Latest accounts
- 2025 · filed on 22 Sep 2026
- Activity
- Retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses (NACE 47741)
Glano (SRL) has been based in Merelbeke-Melle since 2009, active in: retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses. For 2025, it reports a net loss of 6,450 € and equity of 40,901 €; its revenue is not published. Its solvency stands at 14.1%, below the median of its sector (47.4%).
Companies similar to Glano
Companies in the same business, of comparable size and area, outside its group.
- Arterix Retail sale of medical and orthopaedic goods Destelbergen · balance sheet 9,206 €
- Cardon BIO Retail sale of medical and orthopaedic goods Ghent · balance sheet 324,561 €
- SOL Scientifics Retail sale of medical and orthopaedic goods Ghent · balance sheet 426,554 €
- S-Sense Retail sale of medical and orthopaedic goods Ghent · balance sheet 444,654 €
- B&O Retail sale of medical and orthopaedic goods Sint-Martens-Latem · balance sheet 249,098 €
- GP Audiologie Retail sale of medical and orthopaedic goods Anthisnes · balance sheet 439,670 €
- HN Acousticien Retail sale of medical and orthopaedic goods Brussels · balance sheet 183,622 €
- Opti-Service Retail sale of medical and orthopaedic goods Boutersem · balance sheet 285,137 €
Frequently asked questions about Glano
What is the revenue of Glano?
Glano files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Glano?
In Belgium, the VAT number is the company number prefixed with BE: BE0814785548 for Glano, if the company is VAT-registered. Its company number (CBE) is 0814.785.548.
Where is the registered office of Glano?
According to the CBE register, the registered office of Glano is in 9090 Merelbeke-Melle.
What is the equity of Glano?
At the close of the 2025 financial year, the equity of Glano amounts to 40,901 €, a solvency of 14.1% of total assets.
Who manages Glano?
The register lists 2 active mandates at Glano. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Glano
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →